A Practical Guide for Chinese Companies Importing Traditional Chinese Medicine Products into Singapore

---

Key Takeaways

• Singapore’s traditional Chinese medicine (TCM) market offers strong growth potential, but strict regulations make compliance essential.
• Proper classification of Chinese proprietary medicine determines the regulatory pathway.
• Appointing the right local agent directly impacts approval timelines and compliance.
• Labelling, safety checks, and accurate translations are critical to avoid costly setbacks.
• Post-market vigilance protects both brand reputation and consumer safety.

Singapore’s TCM Market: Opportunities with Compliance at the Core

Singapore’s TCM market continues to grow, driven by consumer trust in heritage remedies and the rising popularity of holistic health solutions. For Chinese companies, this creates a significant opportunity to expand into a stable, regulated market. However, strict oversight ensures that every Chinese proprietary medicine entering Singapore meets high standards of safety and quality. Non-compliance can result in shipment delays, rejections, or even seizures, making regulatory readiness a non-negotiable part of market entry.

For companies aiming to import traditional Chinese medicine successfully, a clear understanding of Singapore’s regulatory framework is essential.

1. Classification of TCM Products in Singapore

The first step in market entry is determining how your product is classified. Singapore recognises two primary categories:

• Chinese Proprietary Medicine (CPM): These are usually finished dosage forms like tablets, capsules, or liquids. They must contain active ingredients derived from Chinese medicinal materials and may carry certain approved medicinal claims.
• Health Supplements: These products are intended to supplement the diet without making medicinal or disease-related claims. They face different safety and labelling standards compared to CPMs.

Understanding this distinction is crucial, as it defines whether your TCM product requires registration, notification, or exemption. For example, a company that mistakenly classifies a Chinese herbal supplement as a CPM may submit the wrong set of documents, include unsupported medicinal claims, and face immediate rejection from HSA. This not only delays approval but also adds unnecessary costs to rework the entire submission.

2. Licensing Requirements and Local Representation

No foreign company can sell Chinese proprietary medicine in Singapore without a licensed local agent. This representative serves as your formal link with HSA and is responsible for submitting applications, maintaining records, and managing post-market surveillance.

The choice of agent directly affects your approval timeline. An inexperienced partner may slow things down with incomplete filings or poor communication. By contrast, an established regulatory affairs consultant ensures efficient submissions and consistent compliance, making your entry into Singapore’s market much smoother.

3. Labelling and Safety Requirements

Singapore enforces detailed rules to guarantee that consumers know exactly what they are buying. Labels must include:

• Product name and dosage form.
• Full ingredient list with quantities.
• Directions for use, storage instructions, and expiry date.
• Name and address of both the manufacturer and the local agent.

Safety is equally critical. According to official registration requirements, Chinese proprietary medicine must avoid banned substances, toxic herbs, and contaminants such as heavy metals. Even minor oversights can trigger recalls or withdrawals, damaging both consumer trust and corporate reputation.

4. Listing and Exemption Processes

CPMs undergo a listing process that differs depending on whether the product is locally manufactured or imported. For imported products, the documentary requirements are more extensive than those for local products. While the process is classified as a listing rather than full registration, it remains essential to demonstrate that the product meets quality and safety standards consistent with its claimed indications.

In other cases, exemptions apply to traditional medicinal materials (TMMs), such as raw herbs or substances in their natural state. These are not subject to pre-market approval or licensing by HSA. However, companies are still responsible for ensuring such products are safe, properly labelled, and free from banned substances

may apply if the product meets narrow traditional-use criteria, such as being prepared and sold in small quantities for use according to traditional practice. Even under exemption, companies remain responsible for ensuring the product is safe, properly labelled, and free from banned substances.

Choosing the right pathway is crucial here. Attempting notification for a higher-risk product, for instance, can result in rejection and force the importer to restart the process under the correct route.

5. Common Issues Faced by Chinese Companies

Despite preparation, many companies run into recurring challenges when importing TCM products into Singapore. Some of the most frequent include:

• Missing or inconsistent documentation
• Inclusion of unapproved or banned ingredients
• Translation mistakes in dossiers or labels, which can block notification or mislead consumers.

These issues not only delay approvals but may also damage a company’s credibility with regulators. They are avoidable with early regulatory gap assessments, the use of professional translation and formatting services, and by engaging consultants with local market experience. Proactive preparation ensures smoother communication with HSA, faster approvals, and significantly reduces the risk of costly rework.

6. Post-Market Compliance

Compliance does not end once a product is launched. Companies must continue to:

• Monitor safety and report adverse events.
• Conduct periodic testing and maintain updated records.
• Stay inspection-ready at all times.

Ongoing vigilance ensures that every Chinese proprietary medicine remains compliant and safe for consumers. This commitment not only satisfies regulators but also strengthens your brand’s credibility in a competitive market.

Partnering for Safe and Successful Market Entry

Singapore offers Chinese companies significant growth opportunities in the TCM sector. But success requires not just product quality but also meticulous attention to regulatory details, from correct classification and licensing to post-market vigilance. 

By working with The Reg Consultants, you gain a trusted partner that specialises in guiding companies through the complexities of HSA registration and regulatory support in Singapore. Whether you are introducing a pharmaceutical product, CPM, or health supplements, our team ensures your entry into the local market is compliant, safe, and built for success.

Speak with our team of specialists today.

• Share This Article:

---